Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Leiomyoma × Mifepristone × Clear all

Phase

Phase 2/3 2 Phase 2 2 Phase 4 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pituitary Diseases 3 Pituitary ACTH Hypersecretion 3 Cushing Syndrome 3 ACTH Syndrome, Ectopic 3 Hirsutism 2 Choristoma 2 Adrenal Cortex Neoplasms 2 Meningioma 1 Leiomyoma 1 Breast Cancer Female 1

Interventions

vilaprisan 6 ulipristal acetate 6 asoprisnil 6 telapristone acetate 5 relugolix 5 estradiol, norethindrone drug combination 5 linzagolix 4 elagolix 4 Estradiol 4 Norethindrone Acetate 3 Progestins 2 epigallocatechin gallate 1 Uterine Myomectomy 1 Uterine Artery Embolization 1 Tranexamic Acid 1 Tea 1 Sugars 1 Standard of Care 1 Sodium Chloride 1 Saline Solution 1 Misoprostol 1 Mifepristone 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Leuprolide 1 Laparoscopy 1 Iron 1 Hysterectomy 1 Goserelin 1 Gonadotropin-Releasing Hormone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00133705 2023-09-25

Trial of Mifepristone for Fibroids

University of Rochester

Phase 3 Completed

70 enrolled 6 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡